Cytokinetics Hosts May 19 Fireside Chat at RBC Healthcare Conference with 90-Day Replay
CYTK•Cytokinetics management will host a fireside chat at the RBC Capital Markets Global Healthcare Conference in New York on May 19 at 3:35 PM ET, with live webcast and a 90-day replay archive. This follows positive ACACIA-HCM Phase 3 topline results as Cytokinetics prepares full data presentation and FDA engagement.
1. Event Details
Cytokinetics management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19 at 3:35 PM Eastern Time in New York. The session will feature senior executives discussing recent milestones and strategic priorities.
2. Webcast and Replay
Interested parties can view the live webcast via the Investors & Media section of Cytokinetics’ website, with an on-demand replay available for 90 days post-event. The replay archive ensures stakeholders can access the presentation through mid-August.
3. Pipeline and Regulatory Preparation
Following positive topline results from the ACACIA-HCM Phase 3 trial in non-obstructive hypertrophic cardiomyopathy, Cytokinetics is preparing to unveil full data at an upcoming medical meeting and engage the FDA on next steps. The company continues advancing its cardiac myosin programs including aficamten, omecamtiv mecarbil and ulacamtin toward regulatory milestones.
